Cheap PriceList for Ginkgo Biloba Extract for Saudi Arabia Factory

Cheap PriceList for Ginkgo Biloba Extract for Saudi Arabia Factory

Short Description:

A.      Basic Product Information 【 Product Name 】 Ginkgo Biloba Extract 【 English Name 】 Ginkgo Biloba Extract 【 Plant Sources 】 Ginkgo biloba L. (Dry leaves) 【Effective Components】 Ginkgo flavones , Ginkgolides 【 Specification 】 24%/6%/5ppm,24%/6%/1ppm Water-solution 3g/100ml,  Customizable 【 Extract Solvents 】 Ethanol B.      Main Function a)   ...


Product Detail

Product Tags

, , ,
Cheap PriceList for Ginkgo Biloba Extract for Saudi Arabia Factory Detail:

A.      Basic Product Information

Product Name

Ginkgo Biloba Extract

English Name

Ginkgo Biloba Extract

Plant Sources

Ginkgo biloba L. (Dry leaves)

Effective Components

Ginkgo flavones , Ginkgolides

Specification

24%/6%/5ppm24%/6%/1ppm

Water-solution 3g/100ml,  Customizable

Extract Solvents

Ethanol

B.      Main Function

a)        Dilate blood vesselsprotect the vascular endotheliumpreventarteriospasm.

b)        Inhibit platelet-activating factor and thrombosis, improve blood circulation.

c)        Improving microcirculation and eliminating the damage of free radical etc., Which aims to strengthen cellular nutrition of heart and brain, promote metabolism of heart and brain cells, enhance memory, improve sequela of apoplexy.

C.      Critical To Quality

Ø  Authenticity of identificationQ.gif

Ø  Pesticide residue

Ø  Control for ginkgolic acid

D.      Quality Control & Product Advantage

v  GMP Certificate

v  Using organic raw medicinal material

v  Pesticide residue conforms to international standards.

v  Quality assurance and control system: Prevention management by executing documented procedures strictly aims to guarantee the quality.

v  Technological advantageShare in professional data of product identification technology.

v  Varied specifications, Product customization are acceptable. (We can provide the water-soluble specifications .

E.      Specification

l  Effective components content 

Ginkgo Biloba Extract

Flavones

Terpene lactones

Bilobalide

Ginkgolides  A+B+C

ginkgolic acid

CP2015

24%

6%

/

/

5ppm

USP

22%-27%

5.4%-12.0%

2.6%-5.8%

2.8%-6.2%

5ppm

EP/DAB

22%-27%

5.4%-6.6%

2.6%-3.2%

2.8%-3.4%

5ppm

Provide water-soluble ginkgo biloba extract

Pesticide Residue: Conform to EC396 USP<561>

Item

Specification

Method

Organoleptic indicator

Character

Bright yellowish brown powder or friable block

Organoleptic

Identification

TLC

Conforms

USP- Ginkgo biloba extract powder

HPLC

Conforms

USP- Ginkgo biloba extract powder

Assay

Flavonoid, (Flavonol glycosides, in dry

22.0%~27.0%/NLT 24%

USP- Ginkgo biloba extract powder

Ginkgolides

5.4%~12.0%/ NLT 6%

Bilobalide

2.6%~5.8%

Ginkgolides ABC

2.8%~6.2 %

ginkgolic acid

NMT 5 ppm

Physiochemical indexes

Loss on drying

NMT 5.0%

USP<731>

Heavy Metals

NMT 20 mg/kg

USP<231>

Evaporation Residue

NMT 5%

USP<565>

* Rutin

NMT 4.0%

SW/T 1-2013A3

* Free quercetin

NMT 1%

SW/T 1-2013A4

* Free kaempferol

 NMT 1%

SW/T 1-2013A4

* Free isorhamnetin

NMT 0.4%

SW/T 1-2013A4

Solvent Residue

Ethanol

NMT 5000 mg/kg

USP<467>

Pesticide residue

Acetamiprid

NMT 10μg/kg

USP<561>

Imidacloprid

NMT 10μg/kg

Carbendazim

NMT 10μg/kg

Triadimefon

NMT 10μg/kg

Phorate

NMT 10μg/kg

Phorate-sulfoxide

NMT 10μg/kg

Acephate

NMT 10μg/kg

Dimethoate

NMT 10μg/kg

Microbiology

Total Plate Count

NMT 104 cfu/g

USP<2021>

Yeast and Mold

NMT 103 cfu/g

USP<2021>

E. Coli, /10g

Negative

USP<2022>

Salmonella , /10g

Negative

USP<2022>


Product detail pictures:

Cheap PriceList for Ginkgo Biloba Extract for Saudi Arabia Factory detail pictures


Cheap PriceList for Ginkgo Biloba Extract for Saudi Arabia Factory, The product will supply to all over the world, such as: , , ,



  • Moderator: Nir Hacohen, PhD, Immunologist, MGH Center for Immunology and Inflammatory Diseases, MGH Research Scholar, Associate Professor, Medicine, Harvard Medical School
    Thomas Daniel, MD, Chairman, Celgene Research
    Glenn Dranoff, MD, Global Head of Exploratory Immuno-Oncology, Novartis Institutes for Biomedical Research
    Robert Mulroy, President and CEO, Merrimack Pharmaceuticals
    David Reese, MD, Senior Vice President, Translational Sciences, Amgen
    Scott Rodig, MD, PhD, Associate Professor, BWH
    Arlene Sharpe, MD, PhD, Leader, Cancer Immunology, BWH, DFCI, George Fabyan Professor of Comparative Pathology, Harvard Medical School

    Among the most promising approaches to activating therapeutic antitumor immunity is the blockade of immune checkpoints. Checkpoint blockade, prevention of inhibitory signaling that limits activation or function of tumor antigen-specific T cells responses, is revolutionizing the treatment of many poor-prognosis malignancies. Expert panelists discuss significant long-term cancer remissions, potential cures – in some cases – and how boosting the body’s own defenses is producing stunning results when combined with standard anticancer therapies and other immunotherapies. They will also detail the experimental accines in development that are designed to “wake up” the immune system so it will trigger reliable and effective attacks on cancer cells.



    Introducing Japanese Knotweed (Polygonum cuspidatum); wild food and medicine.

    Send your message to us:

    INQUIRY NOW
    • * CAPTCHA: Please select the Key

    Related Products

    INQUIRY NOW
    • * CAPTCHA: Please select the Car

    WhatsApp Online Chat !
    WhatsApp Online Chat!